Showing results (161-170 of 173) with videos related to
Sort By:
Pageof 18
Lupus|October 7, 2022
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")Zeynep B Erton, Rebecca K Leaf, Danieli de Andrade, et al.Seminars in Arthritis and Rheumatism|June 3, 2019
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohortMassimo Radin, Savino Sciascia, Doruk Erkan, et al.Journal of Thrombosis and Haemostasis : JTH|August 1, 2019
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repositoryMaria Efthymiou, Ian J Mackie, Philip J Lane, et al.Clinical Rheumatology|September 17, 2021
Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide-a report by the HSS International Study GroupYasser Emad, Yasser Ragab, Cal Robinson, et al.International Journal of Cardiology|February 2, 2021
A critical analysis of 57 cases of Hughes-Stovin syndrome (HSS). A report by the HSS International Study Group (HSSISG)Yasser Emad, Yasser Ragab, Melek Kechida, et al.Seminars in Arthritis and Rheumatism|January 7, 2024
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry")Cecile M Yelnik, Zeynep Belce Erton, Elodie Drumez, et al.Lupus|April 3, 2025
Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository ("Registry")Zeynep Belce Erton, Rebecca K Leaf, Danieli de Andrade, et al.Annals of the Rheumatic Diseases|November 20, 2025
Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository ('Registry')Jonathan Thaler, Michael Parides, Danieli Castro Oliveira de Andrade, et al.Arthritis Care & Research|February 3, 2025
Predictors of Mortality in Antiphospholipid Antibody-Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and RepositoryYasaman Ahmadzadeh, Larry S Magder, Danieli Castro Oliveira de Andrade, et al.Clinical and Experimental Rheumatology|July 30, 2025
Antiphospholipid antibody-related clinical manifestations during childhood versus adulthood: descriptive results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repositoryJheel Pandya Bhatt, Marissa Dale, Danieli Castro Oliveira de Andrade, et al.Pageof 18